Phospholipids and Antiphospholipid Syndrome (APS): The Connection Between the Brain, Skin, and Vascular System

Understanding how essential membrane lipids support neurological function, vascular integrity, and skin health—and how autoimmune antibodies in APS can disrupt these systems.

 Introduction

Phospholipids are essential components of nearly every cell in the human body. They provide the structural foundation of biological membranes and participate in cellular communication, lipid transport, inflammation, and neurological function. Their importance is particularly evident in the brain, skin, and vascular system, where normal cellular function depends on the integrity of membranes and the complex signaling processes associated with them.

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by persistent antiphospholipid antibodies (aPL) associated with an increased risk of abnormal blood clotting. Despite its name, APS does not simply involve antibodies attacking all phospholipids. Instead, many clinically important antibodies recognize phospholipid-binding proteins, particularly beta-2 glycoprotein I (β2GPI), and can promote inflammatory and prothrombotic responses.

Understanding the relationship between phospholipid biology and APS helps explain why this condition can affect multiple organs, especially the brain, skin, and vascular system.

 1. Phospholipids: Essential Components of Cellular Life

Phospholipids are amphiphilic molecules, meaning that they contain both hydrophilic (water-attracting) and hydrophobic (water-repelling) regions. This unique molecular structure allows them to organize spontaneously into lipid bilayers, forming the fundamental architecture of cellular membranes.

Within these bilayers, hydrophilic heads face the surrounding aqueous environment, while hydrophobic tails point inward. This arrangement creates a flexible barrier that separates the interior of cells from their external surroundings.

Phospholipids perform several essential biological functions:

- Cell membrane structure: Maintaining membrane organization, flexibility, and cellular compartmentalization.

- Selective permeability: Providing the barrier within which transport proteins regulate the movement of ions, nutrients, and metabolic waste.

- Cellular signaling: Generating signaling molecules that regulate inflammation, growth, survival, and immune responses.

- Lipid transport: Forming part of lipoproteins such as HDL and LDL, which transport cholesterol and triglycerides through the bloodstream.

- Nerve protection: Supporting the structure of myelin, the insulating material surrounding many nerve fibers.

- Lung function: Contributing to pulmonary surfactant, particularly through dipalmitoyl phosphatidylcholine, which reduces alveolar surface tension.

- Medical applications: Serving as components of liposomes and other drug-delivery systems.

These functions illustrate why phospholipids are indispensable not only for cellular survival but also for maintaining communication between organs and tissues.

 2. The Brain: Phospholipids, Neural Communication, and Cognitive Function

The human brain is exceptionally rich in lipids. Approximately 60% of its dry weight consists of lipids, including phospholipids, cholesterol, and other specialized lipid molecules.

Phospholipids contribute to neuronal membranes, synapses, and myelin, supporting electrical signaling, neurotransmitter activity, and neuronal adaptability.

 2.1 Phosphatidylcholine: Supporting Neurotransmitter Production

Phosphatidylcholine (PC) is a major phospholipid in neuronal membranes and an important component of brain lipid metabolism.

PC contains choline, an essential nutrient used to synthesize acetylcholine, a neurotransmitter involved in memory, attention, learning, and neuromuscular communication.

Although phosphatidylcholine contributes to choline metabolism, brain acetylcholine production depends on several factors, including dietary choline availability, neuronal uptake, and enzyme activity. Therefore, increasing phosphatidylcholine intake does not necessarily produce a proportional improvement in cognitive function.

 2.2 Phosphatidylserine: Membrane Organization and Synaptic Plasticity

Phosphatidylserine (PS) is concentrated primarily on the inner leaflet of healthy cell membranes, including neuronal membranes.

It plays important roles in:

- Membrane-associated protein recruitment and activation.

- Intracellular signaling.

- Synaptic activity and neurotransmitter release.

- Neuronal survival and cellular stress responses.

- Recognition and removal of apoptotic cells when PS becomes exposed on the outer membrane surface. 

PS contributes to the molecular processes underlying synaptic plasticity—the capacity of neurons to modify their connections in response to experience. 

Some clinical studies have investigated phosphatidylserine supplementation for age-associated cognitive changes. However, evidence remains limited and inconsistent, and supplementation has not been established as a treatment for dementia or APS-related cognitive impairment. 

 2.3 Phospholipids and Omega-3 Fatty Acid Transport

Docosahexaenoic acid (DHA), an omega-3 fatty acid, is highly enriched in neuronal membranes and contributes to membrane organization, signaling, and synaptic function. 

The blood-brain barrier regulates how DHA enters the central nervous system. 

One important transport pathway involves DHA attached to lysophosphatidylcholine (LPC-DHA), which can be transported across the blood-brain barrier by the MFSD2A transporter.

This mechanism highlights the relationship between phospholipid metabolism and brain nutrition. However, it should not be assumed that all DHA-containing phospholipids cross the blood-brain barrier equally efficiently.

 2.4 Sphingomyelin: Supporting Myelin Integrity 

Sphingomyelin is a phosphosphingolipid that contributes to the composition of myelin, the lipid-rich sheath surrounding many neuronal axons. 

Myelin enables rapid and efficient electrical signal transmission through saltatory conduction. 

Damage to myelin or its supporting cells can impair neurological communication, although the mechanisms responsible for myelin damage differ among neurological diseases. 

 2.5 Phosphatidylinositol: Intracellular Signaling 

Phosphatidylinositol (PI) and its phosphorylated derivatives, known as phosphoinositides, are essential signaling lipids. 

For example, phosphatidylinositol 4,5-bisphosphate (PIP2) can be cleaved into inositol trisphosphate (IP3) and diacylglycerol (DAG).

These signaling molecules regulate intracellular calcium, protein kinase activity, membrane trafficking, and numerous processes involved in neuronal communication.

The phosphoinositide signaling system also participates in inflammatory and immune responses, making it relevant to understanding how cellular activation occurs in autoimmune disorders.

 3. Antiphospholipid Syndrome: When Autoimmunity Disrupts Vascular Function

Antiphospholipid syndrome is a systemic autoimmune condition associated with thrombosis and certain pregnancy complications. 

The principal laboratory markers are:

1. Lupus anticoagulant.

2. Anticardiolipin antibodies, particularly IgG and IgM.

3. Anti-β2 glycoprotein I antibodies, particularly IgG and IgM.

These antibodies may interfere with normal vascular and coagulation regulation through interactions involving phospholipid-binding proteins.

A central target is β2GPI, a circulating protein that can associate with negatively charged phospholipid surfaces.

When pathogenic antibodies bind β2GPI or related complexes, they can promote activation of endothelial cells, platelets, monocytes, and complement pathways.

This contributes to a prothrombotic environment in which blood clots may develop in arteries, veins, or small vessels.

1.        Simplified mechanism of APS-associated thrombosis

2.        Persistent pathogenic antiphospholipid antibodies

3.        Interaction with β2GPI and phospholipid-associated cellular surfaces

4.        Endothelial activation

5.        Platelet and monocyte activation

6.        Complement and coagulation activation

7.        Increased risk of thrombosis 

8.        Brain 

9.        Skin 

Other vascular beds and organs 

Conceptual overview. APS involves multiple interacting mechanisms; not all antibody-positive individuals develop thrombosis.

Importantly, the presence of antiphospholipid antibodies alone does not establish a diagnosis of APS. Diagnosis requires appropriate clinical findings and laboratory assessment, including confirmation of persistent antibodies at least 12 weeks apart.

 4. APS and the Brain: Neurological and Cognitive Consequences 

The brain is particularly vulnerable to disruptions in vascular circulation because neurons require a continuous supply of oxygen and glucose. 

APS can affect neurological function through several mechanisms, including arterial thrombosis, microvascular disease, and potentially antibody-mediated inflammatory processes. 

 Stroke and Transient Ischemic Attack

Ischemic stroke is one of the best-established neurological complications of APS. 

A thrombus in a cerebral artery can interrupt blood flow, resulting in neuronal injury and neurological deficits. 

Transient ischemic attacks (TIAs) may produce temporary neurological symptoms without established infarction but still require urgent medical evaluation. 

 Cognitive Dysfunction 

Some individuals with APS report difficulties involving memory, concentration, attention, and executive functioning. 

Potential contributing mechanisms include cerebral ischemia, small-vessel abnormalities, and associated autoimmune disease. 

Research also examines whether certain antiphospholipid antibodies may exert direct effects on neurological tissues under particular conditions. These mechanisms remain incompletely understood. 

 Migraine and Seizures 

Migraine and seizures have been reported in people with APS and antiphospholipid antibody positivity. 

However, these conditions are not specific to APS, and their presence does not establish that antiphospholipid antibodies are the cause. 

 Phospholipid Biology and Neurological APS 

An important distinction must be made between the normal functions of neuronal phospholipids and the pathological mechanisms of APS.

Although phospholipids are essential for neuronal membrane integrity, APS-related neurological damage is most firmly linked to vascular and thromboinflammatory mechanisms.

There is currently insufficient evidence to conclude that APS generally causes neurological dysfunction by directly depleting phosphatidylcholine, phosphatidylserine, or other neuronal phospholipids.

 5. APS and the Skin: Visible Signs of Vascular Disease 

The skin can provide important clinical clues to APS because its small blood vessels may be affected by vascular occlusion. 

In some patients, skin abnormalities appear before a major thrombotic event. 

 5.1 Livedo Reticularis and Livedo Racemosa 

Livedo reticularis appears as a reddish-purple, net-like discoloration of the skin, commonly affecting the legs. 

Livedo racemosa is generally more irregular, broken, and persistent.

Livedo racemosa is particularly associated with APS and other vascular disorders, although it is not diagnostic on its own.

These patterns can reflect disturbances in cutaneous blood flow, but they do not always indicate proven vascular thrombosis.

 5.2 Retiform Purpura and Skin Necrosis

Retiform purpura consists of branching or angulated purple lesions that may indicate impaired blood supply to the skin.

In severe cases, tissue ischemia can progress to ulceration or necrosis.

Possible causes include thrombotic vasculopathy, vasculitis, embolic disease, infection, and other vascular conditions.

Rapidly developing retiform purpura or necrosis requires urgent medical evaluation.

 5.3 Leg Ulcers

APS-associated vascular impairment can contribute to painful and sometimes recurrent ulcers, especially on the lower extremities.

Such ulcers may be associated with small-vessel occlusion or other circulatory abnormalities.

However, venous insufficiency, arterial disease, infection, and inflammatory disorders must also be considered. 

 5.4 Digital Ischemia 

Digital ischemia may cause fingers or toes to become painful, cold, blue, or purple. 

Severe vascular compromise can result in tissue damage and, rarely, gangrene. 

Sudden painful discoloration or coldness of a digit is a medical emergency because it may represent acute arterial insufficiency.

Other reported cutaneous findings include superficial thrombophlebitis, splinter hemorrhages, and anetoderma.

 6. The Vascular System: A Central Link Between Brain and Skin Manifestations

The vascular endothelium forms the inner lining of blood vessels and serves as an active regulator of coagulation, inflammation, vascular tone, and permeability.

Endothelial cell membranes contain phospholipids that participate in signaling and interactions with circulating blood components.

Under normal circumstances, vascular homeostasis depends on a balance between procoagulant and anticoagulant mechanisms. 

APS can disturb this balance.

Antiphospholipid antibodies may contribute to:

- Increased endothelial expression of procoagulant molecules, including tissue factor.

- Platelet activation and aggregation.

- Complement-mediated inflammatory injury.

- Monocyte activation.

- Altered anticoagulant and fibrinolytic regulation.

- Increased susceptibility to arterial, venous, and microvascular thrombosis.

These processes provide a mechanistic connection between the neurological, dermatological, and systemic vascular complications of APS.

A thrombus in a cerebral artery may cause stroke, while vascular occlusion in the skin may cause retiform purpura or necrosis. Similar processes can affect the kidneys, lungs, heart, and other organs.

 Catastrophic Antiphospholipid Syndrome 

Catastrophic APS (CAPS) is a rare but life-threatening form of the disease characterized by rapidly developing thrombosis, predominantly affecting small vessels, with involvement of multiple organs. 

CAPS can lead to acute kidney injury, respiratory failure, neurological complications, and other forms of organ dysfunction. 

It requires immediate hospital treatment, commonly involving anticoagulation, glucocorticoids, and plasma exchange and/or intravenous immunoglobulin, alongside treatment of triggering factors. 

 7. Methotrexate, Folate Metabolism, Homocysteine, and Thrombosis 

Methotrexate (MTX) is an immunomodulatory medication used to treat several inflammatory and autoimmune conditions, including rheumatoid arthritis and selected manifestations of systemic lupus erythematosus. 

Methotrexate influences folate-dependent metabolic pathways. Depending on dose, supplementation, and individual factors, it may affect homocysteine metabolism. 

Homocysteine is a sulfur-containing amino acid involved in methionine metabolism. 

Elevated homocysteine concentrations have been associated with endothelial dysfunction and cardiovascular risk in observational research.

 A 2023 Case Report 

A 2023 case report described a 56-year-old woman with systemic lupus erythematosus and antiphospholipid antibodies who developed arterial thrombosis after approximately three months of methotrexate treatment, despite receiving warfarin. 

The report proposed that methotrexate-associated disruption of folate metabolism and increased homocysteine might have contributed to the thrombotic event. 

Following discontinuation of methotrexate and administration of B vitamins, homocysteine concentrations reportedly normalized within two months. 

The case raises an important clinical question: could methotrexate-associated hyperhomocysteinemia contribute to thrombosis in patients already at high vascular risk?

 Interpreting the Evidence Carefully 

A single case report cannot establish that methotrexate caused the thrombosis. 

Patients with lupus and antiphospholipid antibodies may have several competing thrombotic risk factors, including disease activity, inflammation, prior thrombosis, cardiovascular comorbidities, and anticoagulation-related factors.

Furthermore, evidence from broader inflammatory disease populations does not establish that low-dose methotrexate generally increases cardiovascular thrombosis. In some settings, controlling systemic inflammation may reduce cardiovascular risk.

Although elevated homocysteine is associated with vascular risk, lowering homocysteine with vitamins has not consistently been shown to prevent thrombotic cardiovascular events. 

The clinical implications are therefore individualized:

- Ensure appropriate folic acid supplementation when low-dose methotrexate is prescribed.

- Consider folate, vitamin B12, renal function, and homocysteine assessment when clinically indicated.

- Evaluate thrombotic symptoms promptly in patients with lupus or APS.

- Review anticoagulation adequacy and other vascular risk factors.

- Avoid interpreting an isolated homocysteine elevation as proof of medication-induced thrombosis.

Routine homocysteine monitoring for every patient taking methotrexate is not an established universal recommendation.

 8. Distinguishing APS Skin Manifestations From Methotrexate Toxicity

Because patients with autoimmune disorders may receive methotrexate, it is important to distinguish APS-associated vascular lesions from medication-related skin reactions.

 

Feature	APS-associated skin disease	Methotrexate skin toxicity
Main mechanism	Vascular dysfunction or thrombosis	Drug toxicity or hypersensitivity
Appearance	Livedo, purpura, ischemia, necrosis	Erythema, rash, erosions, ulcers
Common locations	Legs, fingers, toes	Skin or mucosal surfaces
Itching	Often absent	May occur
Pain	Can be severe with ischemia	Possible with erosions or ulcers
Biopsy	May show thrombotic vasculopathy	May show epidermal injury
Clinical concern	Vascular occlusion	Drug toxicity, including rare severe reactions

Methotrexate may also cause oral ulceration, photosensitivity, and, rarely, severe skin reactions. 

Neither skin appearance nor biopsy findings alone necessarily establish the diagnosis. Clinical history, medication exposure, laboratory testing, and vascular assessment are essential. 

 9. Diagnosis and Clinical Assessment of Suspected APS 

When APS is suspected, evaluation should integrate clinical manifestations with laboratory findings. 

Antiphospholipid antibody testing generally includes lupus anticoagulant, anticardiolipin IgG and IgM, and anti-β2GPI IgG and IgM.

Persistent positivity is typically assessed through repeat testing at least 12 weeks apart. 

In patients with skin lesions, additional investigations may include skin biopsy, Doppler ultrasound, or other vascular imaging, depending on the clinical presentation. 

A biopsy may demonstrate noninflammatory thrombi within cutaneous vessels, supporting a diagnosis of thrombotic vasculopathy. 

However, similar histological findings can occur in other disorders.

Important differential diagnoses include vasculitis, cryoglobulinemia, cholesterol embolization, infection, and medication-related injury. 

It is also important to distinguish formal APS classification criteria, which are designed primarily for research, from individualized clinical diagnosis.

 10. Treatment and Management

Treatment depends on whether a patient has confirmed thrombotic APS, obstetric APS, isolated antibody positivity, or another associated autoimmune condition. 

For many patients with confirmed thrombotic APS, long-term anticoagulation with a vitamin K antagonist such as warfarin is recommended. 

Treatment intensity and duration depend on the type of thrombosis, recurrence risk, and clinical circumstances. 

Direct oral anticoagulants are generally avoided in higher-risk APS, particularly in patients with triple-positive antibody profiles or arterial thrombosis, because of concerns about recurrent events.

Patients with antiphospholipid antibodies but no documented thrombosis do not automatically require anticoagulation.

For cutaneous disease, treatment may also include wound care, management of associated autoimmune inflammation, and vascular assessment.

In pregnancy, APS management often involves carefully selected combinations of low-dose aspirin and heparin, depending on obstetric and thrombotic history. 

Phospholipid supplements, including phosphatidylcholine and phosphatidylserine, have not been established as treatments for APS or substitutes for anticoagulation.

 11. An Integrated Perspective: Brain, Skin, and Vascular Health

The biological importance of phospholipids and the clinical manifestations of APS intersect through cellular membranes, immune signaling, coagulation, and vascular integrity.

Brain

Phospholipids support neuronal membranes, synaptic signaling, and myelin. APS can impair neurological function primarily through thrombotic and vascular mechanisms.

Skin

Phospholipids support cellular membranes and epidermal barrier lipids. APS-related vascular abnormalities may produce livedo, purpura, ulcers, or tissue ischemia.

Vascular system

Membrane phospholipids participate in endothelial and platelet signaling. APS-associated immune activation can shift vascular regulation toward thrombosis.

The shared clinical feature connecting these organ systems is often vascular dysfunction rather than a generalized deficiency of phospholipids.

This distinction is essential because it prevents normal phospholipid physiology from being confused with the specific autoimmune mechanisms responsible for APS.

 Conclusion

Phospholipids are fundamental to the structure and function of the human brain, skin, and vascular system. They support neuronal signaling, membrane integrity, lipid transport, intracellular communication, and many of the processes necessary for tissue survival.

Antiphospholipid syndrome demonstrates how autoimmune reactions involving phospholipid-binding proteins can disturb vascular regulation and lead to potentially serious consequences.

In the brain, APS can contribute to stroke, transient ischemic attacks, and cognitive difficulties. In the skin, vascular abnormalities may appear as livedo racemosa, retiform purpura, ulcers, or digital ischemia. Across the vascular system, endothelial activation, platelet responses, complement activation, and coagulation abnormalities create an increased risk of thrombosis.

The reported relationship between methotrexate, folate metabolism, homocysteine, and thrombosis deserves further investigation, particularly in patients with lupus and pre-existing vascular risk. Nevertheless, isolated case reports cannot establish a general causal relationship.

The central conclusion is that phospholipids are essential for normal cellular function, while APS is primarily an immune-mediated thromboinflammatory disorder involving phospholipid-associated proteins and vascular surfaces. Understanding both aspects provides a more complete framework for interpreting neurological, cutaneous, and vascular manifestations.

Future research into endothelial signaling, β2GPI interactions, complement activation, and phospholipid metabolism may improve our understanding of APS and support the development of more targeted therapies.

Scientific note: This is a narrative educational article, not a systematic review. The 2023 methotrexate case report was summarized from the information provided, rather than independently verified against the original publication. For academic or clinical publication, primary-source references should be added, particularly for APS diagnostic criteria, neurological manifestations, cutaneous disease, anticoagulation recommendations, and the methotrexate case report.

References:

Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies https://pmc.ncbi.nlm.nih.gov/articles/PMC10623835/

Phospholipids to Protect Your Memory and Brain
https://riordanclinic.org/2019/05/phospholipids-to-protect-your-memory-and-brain/

Phospholipases in neuronal function: A role in learning and memory?
https://onlinelibrary.wiley.com/doi/full/10.1111/jnc.14918

Phospholipids: food for the brain
https://foodforthebrain.org/supplements/phospholipids/

Dietary phospholipids: Role in cognitive processes across the lifespan
https://www.sciencedirect.com/science/article/pii/S0149763419310346

Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases
https://pmc.ncbi.nlm.nih.gov/articles/PMC9000073/

Phospholipid Subclasses and Their Biological Functions
https://encyclopedia.pub/entry/39636

Antiphospholipid syndrome
https://www.mayoclinic.org/diseases-conditions/antiphospholipid-syndrome/symptoms-causes/syc-20355831

The heart
https://aps-support.org.uk/about-aps/what-are-the-symptoms/heart

Antiphospholipid Syndrome and Organ Damage – Top 10 Series
https://www.hss.edu/health-library/conditions-and-treatments/antiphospholipid-syndrome-and-organ-damage

What Rheumatologists Need to Know About Antiphospholipid Syndrome
https://www.the-rheumatologist.org/article/what-rheumatologists-need-to-know-about-antiphospholipid-syndrome/

© 2020-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9